BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16411035)

  • 1. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.
    McKenna SP; Doughty N; Meads DM; Doward LC; Pepke-Zaba J
    Qual Life Res; 2006 Feb; 15(1):103-15. PubMed ID: 16411035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation and validation of the Cambridge pulmonary hypertension outcome review for Sweden.
    Selimovic N; Rundqvist B; Kjörk E; Viriden J; Twiss J; McKenna SP
    Scand J Public Health; 2012 Dec; 40(8):777-83. PubMed ID: 23117210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation and Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for Use in Spain.
    Aguirre-Camacho A; Stepanous J; Blanco-Donoso LM; Moreno-Jiménez B; Wilburn J; González-Saiz L; McKenna SP
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):467-473. PubMed ID: 27989660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire.
    Reis A; Twiss J; Vicente M; Gonçalves F; Carvalho L; Meireles J; Melo A; McKenna SP; Almeida L
    Health Qual Life Outcomes; 2016 Jul; 14(1):110. PubMed ID: 27460644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAPTATION AND VALIDATION OF THE CAMBRIDGE PULMONARY HYPERTENSION OUTCOME REVIEW (CAMPHOR) FOR CROATIA.
    Hećimović A; Heaney A; McKenna SP; Basara L; Jakopović M; Vukić Dugac A; Redžepi G; Rotim C; Samaržija M; Jokić-Begić N; Popović-Grle S
    Acta Clin Croat; 2019 Mar; 58(1):3-12. PubMed ID: 31363319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Gomberg-Maitland M; Thenappan T; Rizvi K; Chandra S; Meads DM; McKenna SP
    J Heart Lung Transplant; 2008 Jan; 27(1):124-30. PubMed ID: 18187098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Polish adaptation of the CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Małaczynska-Rajpold K; Smukowska-Gorynia A; Heaney A; McKenna SP; Janus M; Araszkiewicz A; Jankiewicz S; Slawek-Szmyt S; Tomaszewska I; Mularek-Kubzdela T
    Cardiol J; 2020; 27(5):608-615. PubMed ID: 30338844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-cultural adaptation of the Cambridge Pulmonary Hypertension Outcome Review for use in patients with pulmonary hypertension in Colombia.
    Villaquirán C; Moreno S; Dueñas R; Acuña P; Lutz JR; Wilburn J; Heaney A
    J Bras Pneumol; 2019 Jul; 45(6):e20180332. PubMed ID: 31365733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population.
    Ganderton L; Jenkins S; McKenna SP; Gain K; Fowler R; Twiss J; Gabbay E
    Respirology; 2011 Nov; 16(8):1235-40. PubMed ID: 21810146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension.
    Twiss J; McKenna S; Ganderton L; Jenkins S; Ben-L'amri M; Gain K; Fowler R; Gabbay E
    BMC Pulm Med; 2013 Jul; 13():45. PubMed ID: 23844640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The German adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Cima K; Twiss J; Speich R; McKenna SP; Grünig E; Kähler CM; Ehlken N; Treder U; Crawford SR; Huber LC; Ulrich S
    Health Qual Life Outcomes; 2012 Sep; 10():110. PubMed ID: 22971041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-calibrating quality-of-life scores from three pulmonary disorders: implications for comparative-effectiveness research.
    Rouse M; Twiss J; McKenna SP
    J Med Econ; 2016 Jun; 19(6):596-603. PubMed ID: 26824603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French-Canadian and English-Canadian.
    Coffin D; Duval K; Martel S; Granton J; Lefebvre MC; Meads DM; Twiss J; McKenna SP
    Can Respir J; 2008 Mar; 15(2):77-83. PubMed ID: 18354747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
    Chin KM; Gomberg-Maitland M; Channick RN; Cuttica MJ; Fischer A; Frantz RP; Hunsche E; Kleinman L; McConnell JW; McLaughlin VV; Miller CE; Zamanian RT; Zastrow MS; Badesch DB
    Chest; 2018 Oct; 154(4):848-861. PubMed ID: 29705220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying Rasch analysis to evaluate measurement equivalence of different administration formats of the Activity Limitation scale of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Twiss J; McKenna SP; Graham J; Swetz K; Sloan J; Gomberg-Maitland M
    Health Qual Life Outcomes; 2016 Apr; 14():57. PubMed ID: 27062133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire.
    Sakane Y; Yamaguchi M; Yokoi N; Uchino M; Dogru M; Oishi T; Ohashi Y; Ohashi Y
    JAMA Ophthalmol; 2013 Oct; 131(10):1331-8. PubMed ID: 23949096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study.
    Amor-García MÁ; Ibáñez-García S; García-González X; Mombiela T; Villanueva-Bueno C; Herranz-Alonso A; Sanjurjo-Sáez M
    BMC Pulm Med; 2021 Feb; 21(1):48. PubMed ID: 33530979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients.
    Bonner N; Abetz L; Meunier J; Sikirica M; Mathai SC
    Health Qual Life Outcomes; 2013 Oct; 11():161. PubMed ID: 24088389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.